Genesy Project

What Genesy Project does

Genesy Project (operating as Genesy srl) is an Italian genomic blockchain platform founded in 2018 and headquartered in Ferrara, Italy. The company combines IBM Blockchain Hyperledger, IBM Storage cloud infrastructure, third-generation DNA sequencing (Illumina and Oxford Nanopore), and AI/ML to deliver personal whole-genome sequencing and metagenomic microbiome analysis. Its core products are a direct-to-consumer DNA test kit (€249, one-time, including shipping and VAT) offering 100% genome coverage at 5x depth with dozens of genetic reports, and a suite of B2B metagenomics services covering human, animal, air, water, and soil samples. The B2C kit is sold through an e-commerce storefront with samples processed by affiliated laboratories, and the company positions user-owned data, GDPR-compliant handling, and Italian jurisdiction as differentiators versus US-based consumer genomics competitors. The B2B microbiome offering uses Oxford Nanopore sequencing paired with the AirportMD8 air-sampling device for real-time bioaerosol identification and is priced on a custom, multi-year contract basis targeting environmental, agricultural, industrial, and clinical research buyers.

The business model blends one-time kit sales, optional continuous genetic testing services (updated as new clinical studies emerge), and custom enterprise microbiome contracts. Distribution is direct via the company's own website, with no disclosed social media, paid channels, or retail partnerships, and operations are concentrated in Italy with an articulated aspiration to serve the broader European market. Genesy Project appears to be bootstrapped and founder-owned, with no disclosed funding rounds, no public management team, and no revenue figures. The company explicitly cites a large addressable market opportunity in Europe given that nearly all of the 26 million globally sequenced individuals are based in the United States. The platform exposes APIs for data enrichment and a research-partner program requiring explicit user consent for any data sharing.

Name

Genesy Project

Legal name

Genesy srl

Website

https://genesyproject.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Genesy Project is an Italian blockchain-based genomic platform offering direct-to-consumer whole-genome DNA test kits (€249) and B2B metagenomic microbiome analysis services, serving individual consumers and enterprise/research clients across Europe with a focus on data privacy and user-owned genetic data.

Ownership category

akta.pro rank

Product category

Genomic Testing and Microbiome Analysis Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Testing Laboratories and Services (541380)

SIC

Services-Testing Laboratories (8734), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Risk Assessment, Hazard Analysis & Food Defense/Fraud Programs (AFALAAAO)

Keywords

• Genomic sequencing services
• DNA testing kits
• Microbiome analysis
• Metagenomic profiling
• Blockchain genomic data

Headquarters

HQ city

Ferrara

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Technology or R&D, Infrastructure, Personnel, Operations, Marketing or Sales

Revenue model

1. DNA Test Kit Sales: One-time purchase of DNA testing kit at €249 including shipping and VAT. Kit includes saliva collection funnel for sample gathering. Laboratory affiliated partners perform sequencing and generate genetic reports.
2. Continuous Genetic Testing Services: Ongoing genetic analysis services providing updated reports as new clinical studies are published. Tests for physical predispositions and specific pathologies can be performed continuously over months and years. Reports can be submitted to geneticists or third-party software for diagnostic purposes.
3. B2B Microbiome Analysis Services: Enterprise microbiome sequencing services for air, water, soil, animal, and human samples. Pricing depends on sample count, sample types, complexity, urgency, sampling periodicity, and location. Custom reports adapted to specific requirements.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Genesy Project sells direct-to-consumer whole-genome DNA test kits (€249) using saliva samples and third-generation sequencing (Illumina), with results stored on a private IBM Blockchain Hyperledger platform. It also offers B2B metagenomic and microbiome analysis services for human, animal, air, water, and soil samples, supported by AI/ML-based genomic data analysis and APIs for data enrichment.

Product overview

Genesy Project is an Italian genomic blockchain platform offering a suite of DNA and microbiome analysis services powered by blockchain, cloud computing, and artificial intelligence. The core offerings include: (1) DNA Test for personal whole genome sequencing using Illumina third-generation technology, (2) Microbiome Analysis for metagenomic identification of microorganisms in various sample types, and (3) Metagenomics services for comprehensive microbial community profiling. The platform stores genomic data on IBM Blockchain Hyperledger and IBM Storage infrastructure, with APIs enabling interaction with internal and external databases for data enrichment.

Differentiator

Problem solved

Functional benefit

Products and services

• DNA Test (Test del DNA) Personal DNA sequencing service that sequences 100% of the user's DNA using Illumina third-generation sequencing technology at 5x coverage. Delivered via a saliva collection kit; results include genetic health predispositions, personalized medicine recommendations, and ongoing report updates as new clinical studies emerge. Targeted at individual consumers seeking whole-genome health and ancestry insights.
• Microbiome Analysis (Microbioma) Metagenomic analysis of microorganisms (bacteria, viruses, fungi) in human, animal, air, soil, and water samples. Uses third-generation sequencing technologies and provides species-by-species taxonomic classification with continuously updated databases. Offered to enterprises and research institutions with custom pricing per project.

Quantifiable outcome

• 100% genome coverage vs. competitors covering only <2% coding regions
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and strategic.

• IBM (Blockchain Hyperledger)coreTechnology or IntegrationIBM provides the private blockchain platform (Hyperledger) for secure and immutable storage of genomic data and transactions. Advanced smart contracts manage data access and sharing permissions. IBM Storage solutions handle genomic data storage requirements. Critical infrastructure partner for the platform's security architecture.
• Affiliated LaboratoriescoreTechnology or IntegrationPartner laboratories perform DNA extraction and sequencing from saliva samples. Samples processed in Italy (or potentially other countries in the future) using currently available or future testing methods. Laboratories also store saliva and extracted DNA samples for future testing (with prior user consent). Some laboratory partners use unactivated sample portions for calibrating or validating laboratory instruments, equipment, or methods.
• Affiliated Sequencing LaboratoriescoreTechnology or IntegrationSequencing performed by affiliated partner laboratories using third-generation technologies including Oxford Nanopore and Illumina platforms. Labs are calibrated and validated using unactivated sample portions to ensure accuracy of sequencing results.
• Oxford NanoporecoreTechnology or IntegrationThird-generation DNA sequencing technology provider. Used for air sample (bioaerosol) sequencing via AirportMD8 sampling device. Cloud application identifies bacteria, viruses, fungi in real-time. Enables both DNA and RNA analysis with high accuracy.
• Research PartnersstrategicStrategic or Co-development PartnerPartners may include commercial or non-profit organizations conducting or funding scientific research, or developing therapies, medical devices, or related materials for treating, diagnosing, or predicting health conditions. May include entities with financial interests in research outcomes. User explicit consent required before sharing genetic information with research partners.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• 23andMe: Leading direct-to-consumer genetic testing company offering ancestry, health predispositions, and pharmacogenomic reports. Closest direct competitor to Genesy's DTC DNA test in terms of business model, customer (consumer self-purchaser), and use cases.
• MyHeritage: Israel-based DTC DNA testing service with strong European and global distribution. Competes directly with Genesy on consumer genetic testing kits and health/ancestry reports, with similar privacy positioning.
• Ancestry: Direct-to-consumer DNA testing giant focused on ancestry and family history, with a much larger customer database. Overlaps with Genesy's DTC kit model and target consumer segment.
• Dante Labs: Italy-based whole-genome sequencing company offering DTC and B2B services. Nearest geographic and product competitor; both target European consumers with full-genome sequencing and similar pricing.
• Veritas Genetics: Whole-genome sequencing service for consumers and healthcare providers. Comparable on the 100% genome coverage and health-insight value proposition, with overlapping use cases.

Broad incumbents

• BGI Group: Global genomics and sequencing powerhouse with consumer, clinical, and research services including microbiome. Overlaps in sequencing infrastructure and B2B services across multiple sample types.
• Eurofins Genomics: Large European genomics services provider with a broad portfolio including sequencing, genotyping, and microbiome services. Overlaps with Genesy's B2B microbiome and sequencing offerings as a broader incumbent.

Emerging players

• CosmosID: Microbiome and metagenomics services company for environmental, agricultural, and clinical applications. Directly comparable to Genesy's B2B metagenomic and microbiome analysis offerings.
• Color: Clinical and population-scale genetic testing company with both consumer and enterprise offerings. Comparable in targeting health-related genetic insights and serving B2B channels like employers and providers.
• Nebula Genomics: Privacy-focused whole-genome sequencing service using blockchain-based data ownership. Directly comparable technology positioning to Genesy's IBM Hyperledger data-ownership model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/genesy-project

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genesy Project